Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_assertion type Assertion NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_head.
- NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_assertion description "[Combining cytogenetic complexity and transcript data, we found that the subgroup of patients with tumors showing simple karyotypes and SYT/SSX2 fusion had the best clinical outcome (2/8 patients developed metastases), and those with tumors showing complex karyotypes together with SYT/SSX1 fusion the worst (6/7 patients developed metastases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_provenance.
- NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_assertion evidence source_evidence_literature NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_provenance.
- NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_assertion SIO_000772 11433527 NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_provenance.
- NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_assertion wasDerivedFrom befree-20150227 NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_provenance.
- NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_assertion wasGeneratedBy ECO_0000203 NP715011.RAcvqbxsmdH1b_y9eDhJXBC0viVyqaBjvnkEAxXS0PZcM130_provenance.